New White Paper Challenges Thyroid Cancer Risks from GLP-1 Medications Amid Rising Usage A new white paper from the Clayman Thyroid Center debunks fears linking GLP-1 medications like Ozempic and Wegovy to thyroid cancer risk, backed by scientific evidence.

New White Paper Challenges Thyroid Cancer Risks from GLP-1 Medications Amid Rising Usage #USA #Tampa #GLP-1_Medications #Clayman_Thyroid_Center #thyroid_cancer

Alpha Fusion Launches Clinical Trial for Innovative Thyroid Cancer Treatment with af-001 Alpha Fusion has initiated a pivotal clinical trial for af-001, a new alpha-emitting radiopharmaceutical aimed at treating differentiated thyroid cancer patients who are RAI-naïve.

Alpha Fusion Launches Clinical Trial for Innovative Thyroid Cancer Treatment with af-001 #Japan #Tokyo #thyroid_cancer #Alpha_Fusion #af-001

ESTEVE Expands Global Reach with Acquisition of Caprelsa® for Thyroid Cancer Treatment ESTEVE has finalized an agreement with Sanofi to obtain rights to Caprelsa® across more than 50 countries, enhancing treatment options for medullary thyroid cancer.

ESTEVE Expands Global Reach with Acquisition of Caprelsa® for Thyroid Cancer Treatment #Spain #Barcelona #ESTEVE #Caprelsa #thyroid_cancer

ESTEVE Expands Its Portfolio with Acquisition of Caprelsa for Thyroid Cancer Treatment In a strategic move, ESTEVE has acquired the rights for Caprelsa® (vandetanib) to treat medullary thyroid cancer in over 50 countries, enhancing its commitment to specialized healthcare.

ESTEVE Expands Its Portfolio with Acquisition of Caprelsa for Thyroid Cancer Treatment #Spain #Barcelona #ESTEVE #Caprelsa #thyroid_cancer